Now live: molecular tumor boards

Bringing Academic Medicine to Every Community

Intersect on FHIR™ connects specialists at academic medical centers with community and rural hospitals and the patients they serve — through molecular tumor boards, precision genomics, remote monitoring, telehealth, and AI-assisted care.

Rising
Rural cardiovascular death rates, 2010–2022: from 431.6 to 435.0 per 100,000
Falling
Urban rates over the same years: from 369.3 to 345.5 per 100,000 · Source: JACC, CDC WONDER data
FHIR R6
Built on the latest HL7 interoperability standard · U.S. Patent Pending
HL7 CodeX Invited Member
GenomeX & Prior Authorization Use Cases
AHA EmPOWERED to Serve Accelerator
NVIDIA Inception Member
University of Florida Innovation Hub
U.S. Patent Pending
AHA EmPOWERED to Serve Business Accelerator Finalist

Intersect Healthcare Systems has been named a finalist in the American Heart Association's EmPOWERED to Serve Business Accelerator™.

Healthcare equity is not a feature.
It is our foundation.

A patient's zip code should never determine their access to a cardiologist, a genetic counselor, or a specialist in complex chronic disease. Intersect on FHIR™ was purpose-built to dismantle that barrier — connecting the expertise of academic medical centers with the communities that need it most through a hub-and-spoke care delivery model.

Clinician using Intersect platform
Live Molecular tumor board
workflow
🏥

Hub-and-Spoke Care Delivery

Academic medical centers serve as clinical hubs, extending specialist reach to local primary care providers and patients across entire regional service areas.

❤️

Cardiovascular & Genomic Risk

Familial hypercholesterolemia alone affects about 1 in 250 Americans, and most cases go undiagnosed. Our genomic medicine module helps find them.

📱

Patient-Centered Mobile Access

Patients receive visit summaries, medication updates, appointment reminders, and direct messaging through a dedicated mobile application.

🌎

Designed for National Scale

Cloud-native architecture with no geographic constraints. A single health network deployment can impact tens of thousands of patients across multiple states.

One platform. Every dimension of care.

Where other solutions address one capability in isolation, Intersect on FHIR™ integrates the full care continuum on a single platform built on HL7 FHIR R6.

🔬
Molecular Tumor Boards

Case preparation, sessions, notes, and recommendations for molecular tumor boards — with ClinVar, CIViC, DailyMed, and NCI clinical trial lookups built in.

Now Live
🧬
Precision Genomic Medicine

Five genetic testing panel views including Pharmacogenomics, HBOC, Lynch Syndrome, Cardiovascular Genetics, and Cardiac Arrhythmia — connected to the tumor board workflow.

CodeX GenomeX
📡
Remote Patient Monitoring

Continuous wearable integration with automated alerts for out-of-range vitals, trending deterioration, and missed readings — directly surfaced in the clinician dashboard.

Real-Time Alerts
🎥
Integrated Telehealth

Secure video visits with AI-assisted SOAP note generation. Providers spend less time on documentation and more time on care. Patient visit summaries delivered directly to the mobile app.

AI-Assisted
💊
Clinical Decision Support

Drug interaction detection, allergy alerts, duplicate order identification, and pharmacogenomics guidance — all at the point of care, in real time.

Evidence-Based
📋
Computerized Provider Order Entry

Six order types including Rx with RxNorm search, Lab, Imaging, Referral, DME/Devices, and PT/Rehab — integrated with clinical workflows and patient records.

Full CPOE
📝
AI-Assisted Prior Authorization

Reads the clinical record against payer requirements, completes the documentation, and flags what is missing before a request is submitted — so fewer requests come back denied.

In Development
🔒
Role-Based Security

Every request is authorized by role and by patient, so each user sees only the records they are entitled to — with access decisions logged for audit.

Access Controlled
🔗
FHIR Interoperability

Built on the HL7 FHIR standard, designed to connect with EHRs, payers, labs, and health information exchanges — across vendors, today and as standards evolve.

Standards-Based

Prior authorization, before the denial

Denials that are later overturned cost health systems rework, delayed revenue, and delayed treatment. Intersect reads the clinical record against each payer's requirements and flags missing documentation before a request goes out. Oncology comes first, through our work in HL7 CodeX — and the same engine extends to every specialty.

Status
In Development
Oncology first
Expanding to all specialties

Recurring revenue aligned with outcomes.

Intersect on FHIR™ operates on a per-patient-per-month subscription model. Health systems license a dedicated platform instance, with fees that scale directly with enrolled patient populations.

Per-Patient Subscription

Monthly recurring revenue scales with patient enrollment. Predictable for clients, sustainable for growth.

Dedicated Deployments

Each health system receives their own instance — ensuring data sovereignty, security, and custom workflow configuration.

Implementation Services

Onboarding, integration, and clinical workflow customization services support each new health system deployment.

Premium Modules

Precision genomic medicine, AI documentation, and advanced analytics available as expanded capability tiers.

Invited Member of HL7 CodeX

Intersect Healthcare Systems holds invited membership in CodeX, the HL7 FHIR Accelerator. We contribute as a developer in the GenomeX domain — national standards for molecular tumor boards and pathogen genomics — and in the Prior Authorization in Oncology use case.

Membership Status
HL7 CodeX
Developer / Implementer
GenomeX · Prior Authorization

From the FHIRhose

Ready to extend your reach?

See how Intersect on FHIR™ can connect your academic medical center with the communities that need you most.

Schedule a Conversation